Exacerbation of anemia from hereditary spherocytosis during pregnancy
Authors:
- Katherine E. EconomyKEKatherine E. Economy
- Ayana WatkinsAWAyana Watkins
- Arielle L. LangerALArielle L. Langer
Open Access
- 13 January 2026
- journal article
- Published by Elsevier in Blood Red Cells & Iron
- Vol. 2 (1)
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Postpartum Hemorrhage Trends and Outcomes in the United States, 2000–2019Obstetrics & Gynecology, 2022
- The Complexity of Genotype‐Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 PatientsHemaSphere, 2019
- Flow Cytometric Eosin-5′-Maleimide Test is a Sensitive Screen for Hereditary SpherocytosisIndian Journal of Hematology and Blood Transfusion, 2017
- Contemporary Uses of Erythropoietin in PregnancyObstetrical & Gynecological Survey, 2013
- Prevalence of pulmonary hypertension in hereditary spherocytosisAmerican Journal of Hematology, 2011
- Eosin‐5‐maleimide binding to band 3 and Rh‐related proteins forms the basis of a screening test for hereditary spherocytosisBritish Journal of Haematology, 2003
- Experience with eosin-5′-maleimide as a diagnostic tool for red cell membrane cytoskeleton disordersClinical and Laboratory Haematology, 2003
- Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: A case report and review of the literatureAmerican Journal of Hematology, 1998
- Spherocytosis, splenectomy, strokes, and heart attacksThe Lancet, 1997
- Pregnancy and hereditary spherocytosisArchives of Gynecology and Obstetrics, 1993